“Receiving a letter from the United States Senate Finance Committee is a frightening experience,” said a CME professional from a major pharmaceutical company during a hot-topics session at the Alliance for CME annual conference. From the comments other attendees made, it appears that many CME professionals, whether on the industry or provider side, agree that the government's focus on funding is definitely something to worry about. Speakers explained that the Senate Committee on Finance had ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Senate Extends Pharma Grants Probe, you'll get exclusive access to a large archive of premium content.

Already registered? here.